A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs

Trial Profile

A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jan 2015

At a glance

  • Drugs Carbamazepine (Primary) ; Gabapentin (Primary) ; Lamotrigine (Primary) ; Oxcarbazepine (Primary) ; Topiramate (Primary) ; Valproic acid (Primary)
  • Indications Epilepsy; Partial epilepsies
  • Focus Therapeutic Use
  • Acronyms SANAD
  • Most Recent Events

    • 29 Aug 2009 Actual number of patients changed from 2437 to 3000.
    • 24 Mar 2007 Results have been published.
    • 15 Jul 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top